MedTrace Logo

The Role of Genetic Factors in the Development of Arterial Hypertension in the Kazakh Population

NCT05088486 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2023-03-14

No results posted yet for this study

Summary

This is a GWAS study that aims to identify possible candidate genes associate to arterial hypertension by exploring single nucleotide polymorphism (SNP) in a group of arterial hypertension, in the Kazakh population. The investigators hypothesize that the careful phenotyping of the subject sand matching with increase the power to find SNP significantly associate with arterial hypertension

Conditions

  • Arterial Hypertension

Interventions

GENETIC

DNA analysis

GWAS

Sponsors & Collaborators

  • Asfendiyarov Kazakh National Medical University

    lead OTHER

Principal Investigators

  • Raushan Karibayeva, Doctor of medical sciences · Deputy head of Gerontology Center of Medical Centre Hospital of the President's Affairs Administration of the Republic of Kazakhstan

  • Tamara Vochshenkova, MBA · Deputy head of Gerontology Center of Medical Centre Hospital of the President's Affairs Administration of the Republic of Kazakhstan

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-30
Primary Completion
2023-01-20
Completion
2023-01-20

Countries

  • Kazakhstan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05088486 on ClinicalTrials.gov